Back to search

Article

Risks associated with the combination of Darolutamide and Docetaxel in interstitial lung disease : a pharmacovigilance study based on the FAERS database

2026-07-23

Abstract excerpt

<title>Abstract</title> <p>Darolutamide plus docetaxel is a first-line treatment-intensification regimen for metastatic hormone-sensitive prostate cancer, but whether it has a distinctive pulmonary safety signal remains unclear. We analyzed FAERS reports for darolutamide + docetaxel, enzalutamide + docetaxel, and abiraterone + docetaxel using disproportionality analyses at the system organ class and preferred-ter...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e9eef91f-d3bf-5571-9fbf-20c536d682d2
DOI
10.21203/rs.3.rs-10227539/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Risks associated with the combination of Darolutamide and Docetaxel in interstitial lung disease : a pharmacovigilance study based on the FAERS databaseDOI 10.21203/rs.3.rs-10227539/v1
Effects of enzalutamide, apalutamide, and darolutamide in metastatic hormone-sensitive prostate cancer with or without docetaxel: a systematic review and network meta-analysisSemantic proximity
Unveiling novel potential drug targets for lung cancer through Mendelian randomization analysis.Semantic proximity
Reported Drug Spectrum and Disproportionality Signals for Malignant Neoplasm Progression in FAERS: A Real-World Pharmacovigilance StudySemantic proximity
Cardiotoxicity Associated with Targeted Therapies in Lung Cancer: A Retrospective Cohort Study of 2,427 Patients with FAERS Pharmacovigilance ValidationSemantic proximity
Investigation of Key Molecular Mechanisms of 6PPDQ in Breast Cancer Development and Progression through Network Toxicology and Computational SimulationSemantic proximity
The Interplay Between Molecular Architecture, Pharmacology, and Suspected Adverse Drug Reactions Associated with Non-Steroidal Androgen Antagonists in The United KingdomSemantic proximity
Survival outcome of chemotherapy-naïve castration-resistant prostate cancer treated with new-generation androgen receptor axis-targeted agents in real-world analysisSemantic proximity
Exploring the Association Between Upadacitinib and Venous Thromboembolism: An Integrated Analysis of Adverse Drug Events and Network Toxicology MechanismsSemantic proximity
Pharmacogenomics-Driven Multimodal Data Integration Improves Predictions of Adverse Drug Reactions in Cancer Patients using Machine LearningSemantic proximity
Distinct Adverse Event Profiles of Eight Chemotherapeutic Agents: A FAERS Database Analysis Focusing on Peripheral NeuropathySemantic proximity
ProToxNet: Expression-Aware Proteome-Wide Binding for Tissue-Stratified Adverse Event PredictionSemantic proximity
Integrative analysis of FAERS, network toxicology, and Mendelian randomization identifies potential targets in paclitaxel-associated systemic sclerosis.Semantic proximity
Select a neighboring publication to make it the new centre.